---
title: "Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Builds Foundation for Biomarker-Driven Cancer Therapy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296130343.md"
description: "Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Builds Foundation for Biomarker-Driven Cancer Therapy"
datetime: "2026-08-17T16:31:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296130343.md)
  - [en](https://longbridge.com/en/news/296130343.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296130343.md)
generator: "portal-rs"
---

# Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Builds Foundation for Biomarker-Driven Cancer Therapy


### Related Stocks

- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)

## Related News & Research

- [From Molecule to Medicine: Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Aligns ONC010 for Clinical Development](https://longbridge.com/en/news/298347552.md)
- [Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Builds Manufacturing, IND and Capital Foundation Ahead of Planned Clinical Translation](https://longbridge.com/en/news/298480125.md)
- [Onco-Innovations reports interim three-species microsome metabolism results for ONC010 API A83B4C63](https://longbridge.com/en/news/298509082.md)
- [ALXO: Biomarker-driven CD47 and novel EGFR ADC programs show promise for hard-to-treat cancers](https://longbridge.com/en/news/298621322.md)
- [Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Enters LOI for Exclusive Option on LAG-3 Inhibitor Program](https://longbridge.com/en/news/296513179.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**